1. Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N
   Michal Grzmil et al, 2021, Pharmaceutics CrossRef
2. Role of autophagy in regulating the radiosensitivity of tumor cells
   Yong Xin et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
3. mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
   Samantha Exner et al, 2021, Frontiers in Oncology CrossRef
4. Traditional Chinese medicine Danggui Buxue Tang inhibits colorectal cancer growth through induction of autophagic cell death
   Shun-Ting Chen et al, 2017, Oncotarget CrossRef
5. Synthetic Vulnerabilities in the KRAS Pathway
   Marta Roman et al, 2022, Cancers CrossRef
6. Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors
   Johannes Zellmer et al, 2022, Biomedicines CrossRef
7. To live or let die: Unclear task of autophagy in the radiosensitization battle
   Martin Ondrej et al, 2016, Radiotherapy and Oncology CrossRef
8. Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer
   Michal Grzmil et al, 2022, Cancers CrossRef